About this episode
TWiV provides an update on hepatitis of unknown etiology in children, an experimental nanoparticle vaccine for Epstein-Barr virus, and minimal impact of bamlanivimab therapy on antiviral antibodies induced by vaccination.
Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Hepatitis of unknown etiology (MMWR)
- Clinical recognition of monkeypox (CDC)
- Epstein-Barr virus nanoparticle vaccine (Cell Rep Med)
- Minimal impact of mAb therapy on COVID vaccine induced antibodies (Sci Trans Med)
- Letters read on TWiV 911
- Timestamps by Jolene. Thanks!
Weekly Picks
Brianne – A Frog So Small, It Could Not Frog
Kathy – A Grand Night In: The Story of Aardman
Rich – Archive
Vincent – Bandwagoning by Heran Darwin
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology